Patents by Inventor William Steve Ammons

William Steve Ammons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating conditions associated with intestinal ischemia/reperfusion
    Patent number: 6767893
    Abstract: The present invention provides methods of treating adverse physiological effects associated with intestinal ischemia/reperfusion by administering to a subject suffering from the effects of intestinal ischemia/reperfusion an effective amount of a BPI protein product.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: July 27, 2004
    Assignee: Xoma Corporation
    Inventors: William Steve Ammons, Károly M. Mészäros
  • METHOD OF TREATING CONDITIONS ASSOCIATED WITH INTESTINAL ISCHEMIA/REPERFUSION
    Publication number: 20030171265
    Abstract: The present invention provides methods of treating adverse physiological effects associated with intestinal ischemia/reperfusion by administering to a subject suffering from the effects of intestinal ischemia/reperfusion an effective amount of a BPI protein product.
    Type: Application
    Filed: October 12, 1999
    Publication date: September 11, 2003
    Inventors: WILLIAM STEVE AMMONS, KAROLY M. MESZAROS
  • Antithrombotic materials and methods
    Patent number: 6599881
    Abstract: Antithrombotic materials and methods are provided for the treatment of thrombotic disorders, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: July 29, 2003
    Assignee: Xoma Corporation
    Inventors: Mark L. White, William Steve Ammons
  • Therapeutic uses of bactericidal/permeability-increasing protein dimer products
    Patent number: 6277821
    Abstract: Improved therapeutic compositions, methods and uses of bactericidal/permeability-increasing protein (BPI) products involve use of dimeric forms of BPI protein product monomers characterized by enhanced in vivo biological activity. Preferred formulations include 50 percent or more by weight dimeric product and preferred therapeutic uses include endotoxin neutralization and heparin neutralization.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: August 21, 2001
    Assignee: Xoma Corporation
    Inventors: William Steve Ammons, Roger G. Little
  • Antithrombotic materials and methods
    Patent number: 6107280
    Abstract: Antithrombotic materials and methods are provided for the treatment of thrombotic disorders, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: August 22, 2000
    Assignee: XOMA Corporation
    Inventors: Mark L. White, William Steve Ammons
  • Method of treating conditions associated with intestinal ischemia/reperfusion
    Patent number: 6017881
    Abstract: The present invention provides methods of treating adverse physiological effects associated with intestinal ischemia/reperfusion by administering to a subject suffering from the effects of intestinal ischemia/reperfusion an effective amount of a BPI protein product.
    Type: Grant
    Filed: November 25, 1996
    Date of Patent: January 25, 2000
    Assignee: XOMA Corporation
    Inventors: William Steve Ammons, Karoly M. Meszaros
  • Antithrombotic materials and methods
    Patent number: 5935930
    Abstract: Antithrombotic materials and methods are provided for the treatment of thrombotic disorders, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: April 20, 1998
    Date of Patent: August 10, 1999
    Assignee: Xoma Corporation
    Inventors: Mark L. White, William Steve Ammons
  • Therapeutic uses of bactericidal/permeability-increasing protein dimer products
    Patent number: 5856302
    Abstract: Improved therapeutic compositions, methods and uses of bactericidal/permeability-increasing protein (BPI) products involve use of dimeric forms of BPI protein product monomers characterized by enhanced in vivo biological activity. Preferred formulations include 50 percent or more by weight dimeric product and preferred therapeutic uses include endotoxin neutralization and heparin neutralization.
    Type: Grant
    Filed: December 16, 1996
    Date of Patent: January 5, 1999
    Assignee: XOMA Corporation
    Inventors: William Steve Ammons, Roger G. Little
  • Antithrombotic materials and methods
    Patent number: 5741779
    Abstract: Antithrombotic materials and methods are provided for the treatment of thrombotic disorders, in which therapeutically effective amounts of BPI protein products are administered.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: April 21, 1998
    Assignee: XOMA Corporation
    Inventors: Mark L. White, William Steve Ammons
  • Therapeutic uses of bactericidal-permeability-increasing protein dimer products
    Patent number: 5703038
    Abstract: Improved therapeutic uses of bactericidal/permeability-increasing protein (BPI) involve use of BPI protein product formulations in the form of physiologically stable dimeric associations of BPI protein product monomers characterized by enhanced in vivo biological activity. Preferred formulations include 50 percent or more by weight dimeric product.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 30, 1997
    Assignee: XOMA Corporation
    Inventors: William Steve Ammons, Roger G. Little